Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoadside Real Regulatory News (ROAD)

Share Price Information for Roadside Real (ROAD)

Share Price is delayed by 15 minutes
Get Live Data
59.50    0.00 (0.00%)
Bid:
59.00
Ask:
60.00
Spread: 1.00 (1.695%)
Market Cap: £106.07m
ROAD Live PriceLast checked at - London Stock Exchange

Intraday Roadside Real Share Chart

Update on Acquisitions and Debt Facility

29 Apr 2026 07:00

RNS Number : 3233C
Roadside Real Estate PLC
29 April 2026
Β 

29 April 2026

Roadside Real Estate PLC

("Roadside", the "Company" or the "Group")

Update on Acquisitions and Debt Facility

Roadside (AIM: ROAD), theΒ UKΒ energy forecourt real estate business provides the following update in respect of the acquisitions of D.A. Roberts Fuels Ltd ("DAR") and Hoch Group Ltd ("HOCH").

Following the exercise of the put option with CGV Ventures 1 Ltd ("CGV"), announced on 31 March 2026, the Β£14 million proceeds are now expected to be received by the end of May 2026. This is due to the finalisation of recently introduced regulatory requirements in the underlying jurisdictions. The acquisition of DAR will complete shortly after receipt of the funds from CGV. The Company has paid a deposit of Β£1.36 million to DAR, with the balance of the net cash consideration of Β£10.5 million due on completion. The Company has extended the latest completion date to 31 May 2026.

The acquisition of HOCH remains on track to complete by 31 May 2026. On 13 April 2026, Roadside announced that the acquisition consideration of Β£28.6 million would be partly funded by a Β£25 million debt facility provided by HSBC, with the balance of the consideration of Β£3.6 million funded by the drawdown of facilities provided by Tarncourt Capital Limited. The terms of the HSBC debt facility are now agreed, and the facility agreement will be executed on the acquisition completion date.

Β 

Enquiries

Roadside Real Estate PLC

Steve Carson, Chairman

Charles Dickson, Chief Executive Officer

Douglas Benzie, Chief Financial Officer

c/o Montfort

Montfort

Ann-marie Wilkinson

Alex Everett

Β 

+44 (0)7730 623815

+44 (0)7780 431533

Cavendish Capital Markets LimitedΒ (Nomad & Joint Corporate Broker)

Matt Goode / Seamus Fricker / Elysia Bough (Corporate Finance)

Matt Lewis / Harriet Ward (ECM)

Β 

Β 

+44 (0) 20 7220 0500

Shore CapitalΒ (Joint Corporate Broker)

Ben Canning (Corporate Broking)

Stephane Auton / James Thomas / Harry Davies-Ball (Corporate Advisory)

Β 

+44 (0)20 7408 4050

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQILMMTMTBTMRF
12
Date   Source Headline
15th Jun 20267:00 amRNSReceipt of Proceeds from Second Tranche Put Option
28th May 20267:00 amRNSUpdate on Acquisitions
21st May 20267:00 amRNSProceeds from First Tranche of Put Option
29th Apr 20267:00 amRNSUpdate on Acquisitions and Debt Facility
23rd Apr 20267:00 amRNSDirector Dealings
20th Apr 20267:09 amRNSDirector Dealings and Changes to Concert Party
16th Apr 20267:00 amRNSDirector Dealings and Changes to Concert Party
13th Apr 202610:24 amRNSREPLACE: Acquisition of Hoch Group Limited
13th Apr 20267:30 amRNSGrant of Share Options
13th Apr 20267:00 amRNS£28.6 million acquisition of Hoch Group Limited
31st Mar 20267:00 amRNSExercise of First Tranche of Put Option Agreement
27th Mar 20267:00 amRNSAppointment of Joint Corporate Broker
24th Mar 202611:40 amRNSResult of AGM and Directorate Changes
24th Mar 20267:00 amRNSAGM Statement
13th Mar 202612:16 pmRNSNotification of Major Holdings
13th Mar 202612:16 pmRNSNotification of Major Holdings
27th Feb 20262:00 pmRNSNotice of AGM
25th Feb 20265:37 pmRNSNotification of Major Holdings
25th Feb 20267:22 amRNSCompletion of Acquisition
25th Feb 20267:00 amRNSNotification of Major Holdings
17th Feb 20266:28 pmRNSResult of Placing and Subscription
17th Feb 20265:36 pmRNSProposed Placing, Subscription & Acquisition
17th Feb 20265:03 pmRNSNotice of AGM & Board Appointment
17th Feb 20264:57 pmRNSIssue of Equity
17th Feb 20264:51 pmRNSAnnual Financial Report
9th Feb 20267:00 amRNSAmendment to Put Option Agreement
27th Jan 20267:40 amRNSNotice of Results
24th Dec 20257:00 amRNSAcquisition
28th Nov 202510:20 amRNSNotification of Major Holdings
27th Nov 20254:22 pmRNSNotification of Major Holdings
19th Nov 20253:10 pmRNSNotification of Major Holdings
10th Nov 20255:00 pmRNSNotification of Major Holdings
14th Oct 20257:00 amRNSYear End Update and Notice of Results 2025
29th Sep 20252:48 pmRNSResult of General Meeting
12th Sep 20257:00 amRNSDisposal
9th Sep 20257:00 amRNSAppointment of COO and LTIP Implementation
4th Jul 20257:00 amRNSAcquisition
30th Jun 20257:00 amRNSInterim Results for the six months ended 31.03.25
26th Jun 20257:00 amRNSSigning of £48 million put option agreement
17th Jun 202511:46 amRNSResult of AGM
23rd May 20257:00 amRNSNotice of Annual General Meeting (“AGM”)
8th May 20257:00 amRNSAppointment of new Chair
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSUpdate on partial sale of CSS shareholding to CGV
18th Feb 20257:00 amRNS-RUpdate on Cambridge Sleep Sciences
24th Dec 20247:00 amRNSFinal results for the year ended 30 September 2024
13th Dec 20247:15 amRNSNotice of results
13th Dec 20247:00 amRNSJoint venture acquisition
28th Oct 20247:00 amRNSRoadside JV acquires 12 stores from Lidl
1st Oct 20247:00 amRNSPartial sale of CSS shareholding
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.